Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial.
AUTHORS
Bress
AP ,
King
JB ,
Kreider
KE ,
Beddhu
S ,
Simmons
DL ,
Cheung
AK ,
Zhang
Y ,
Doumas
M ,
Nord
J ,
Sweeney
ME ,
Taylor
AA ,
Herring
C ,
Kostis
WJ ,
Powell
J ,
Rastogi
A ,
Roumie
CL ,
Wiggers
A ,
Williams
JS ,
Yunis
R ,
Zias
A ,
Evans
GW ,
Greene
T ,
Rocco
MV ,
Cushman
WC ,
Reboussin
DM ,
Feinglos
MN ,
Papademetriou
V ,
,
. Diabetes care. 2017 8 9; ().
- PMID: 28793997 [PubMed].
ABSTRACT
To determine whether the effects of intensive (<120 mmHg) compared with standard (<140 mmHg) systolic blood pressure (SBP) treatment are different among those with prediabetes versus those with fasting normoglycemia at baseline in the Systolic Blood Pressure Intervention Trial (SPRINT).
To determine whether the effects of intensive (<120 mmHg) compared with standard (<140 mmHg) systolic blood pressure (SBP) treatment are different among those with prediabetes versus those with fasting normoglycemia at baseline in the Systolic Blood Pressure Intervention Trial (SPRINT).